Facilitating Antibacterial Drug Development in a Time of Great Need.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 27481949.
- Also identified by DOI 10.1093/cid/ciw257.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The continued development of new antibacterial drugs is critical to meet patient and public health needs. In this editorial, authors from the US Food and Drug Administration and European Medicines Agency reflect on the role of public-private partnerships and the development of clinical trials networks as agents to guide and perform quality studies of antibacterial drugs.
Medical subject headings
- Anti-Bacterial Agents
- Drug Discovery
- Public-Private Sector Partnerships